← Back
Data updated: Mar 10, 2026
IMMUNEX
Oncology
IMMUNEX is a biotechnology company focused on Oncology.
1959
Since
4
Drugs
-
Trials
9
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Strength Pro
Loading...